Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
06/2000
06/29/2000WO2000037940A1 Diagnostic method for autoimmune arthritis
06/29/2000WO2000037939A1 Test device for immunoassays
06/29/2000WO2000037938A1 FUNCTION-BASED SMALL MOLECULAR WEIGHT COMPOUND SCREENING SYSTEM IN $i(DROSOPHILA MELANOGASTER)
06/29/2000WO2000037937A1 Method and device for separating serum
06/29/2000WO2000037936A1 Laboratory test for assessing the tendency of a gasoline, optionally containing an additive, to cause deposits while the engine is running
06/29/2000WO2000037935A1 Matric potential responder improvements
06/29/2000WO2000037934A1 Method and apparatus for selective biological material detection
06/29/2000WO2000037933A1 Stochastic array processing of sensor measurements to detect and quantify analytes
06/29/2000WO2000037921A1 Pendulum rolling resistance test
06/29/2000WO2000037918A2 A method and an apparatus for cutting of tissue blocks
06/29/2000WO2000037699A1 Method for predicting the microstructure of solidifying cast iron
06/29/2000WO2000037698A1 Method for determining the needed amount of structure modifying agent to be added to cast iron
06/29/2000WO2000037685A2 Method of identifying a psychotropic agent using differential gene expression
06/29/2000WO2000037683A2 High throughput assay system for monitoring ests
06/29/2000WO2000037681A1 BIOASSAY FOR IDENTIFYING ESTROGEN RECEPTOR-β/α SELECTIVE MODULATORS
06/29/2000WO2000037680A1 Method for the detection of specific nucleic acid sequences by polymerase nucleotide incorporation
06/29/2000WO2000037676A1 Method of sequence identification
06/29/2000WO2000037674A1 Nucleic acid sequencing method
06/29/2000WO2000037658A2 Chemically modified enzymes with multiple charged variants
06/29/2000WO2000037646A2 Group b streptococcus proteins, and their use
06/29/2000WO2000037643A2 Compounds for immunotherapy and diagnosis of colon cancer and methods for their use
06/29/2000WO2000037640A2 Compositions and methods for the treatment of tumor
06/29/2000WO2000037633A1 Rna polymerase transcription promoters and method for determining base sequence
06/29/2000WO2000037632A1 Monoclonal antibody against apolipoprotein a-i
06/29/2000WO2000037620A1 Crystalline form of activated trap and use thereof for structure-based drug design
06/29/2000WO2000037613A2 Human akt-3
06/29/2000WO2000037611A1 Cell lineage markers
06/29/2000WO2000037504A2 Human monoclonal antibodies to ctla-4
06/29/2000WO2000037503A1 Compositions and methods for generating monoclonal antibodies representative of a specific cell type
06/29/2000WO2000037494A2 Chlamydia trachomatis antigens
06/29/2000WO2000037493A2 Type iii secretion system antigens from bordetella pertussis
06/29/2000WO2000037491A2 Dnas encoding proteins with signal sequences
06/29/2000WO2000037490A2 Outer surface proteins, their genes, and their use
06/29/2000WO2000037489A2 Fragment of the gylcoprotein cd55/daf for producing highly effective anti-tumour medicaments and method for using the same
06/29/2000WO2000037483A1 Protein-protein interactions in neurodegenerative disorders
06/29/2000WO2000037448A1 Fluorescent dyes for solid phase and solution phase screening
06/29/2000WO2000037163A1 Integrated portable biological detection system
06/29/2000WO2000037112A1 Pharmaceutical compositions comprising immortalised endothelial cells
06/29/2000WO2000037095A1 Cardiac muscle function and manipulation
06/29/2000WO2000037093A1 Bone resorption inhibitors
06/29/2000WO2000037089A1 Cyclic adenosine diphosphate ribose analogues for modulating t cell activity
06/29/2000WO2000037085A1 Treatment of diseases involving cyst formation
06/29/2000WO2000037077A1 Assays for ligands for nuclear receptors
06/29/2000WO2000037025A2 Antibodies to truncated vegf-d and uses thereof
06/29/2000WO2000036910A1 Msh5 ablated mice and uses therefor
06/29/2000WO2000017221A9 Method of measuring protein-protein interactions in living cells
06/29/2000WO2000011024A3 Novel optical architectures for microvolume laser-scanning cytometers
06/29/2000WO2000009076A8 Imaging with tc-99m labeled fibrin-alpha-chain peptide
06/29/2000WO2000008466A9 Analytical test device and method
06/29/2000WO2000008180A3 HUMAN cDNAs ENCODING POLYPEPTIDES HAVING KINASE FUNCTIONS
06/29/2000WO2000008145A3 Novel genes in control of hematopoiesis
06/29/2000WO2000006737A3 Streptococcus pneumoniae proteins and nucleic acid molecules
06/29/2000WO2000006605A3 Heterominibodies
06/29/2000WO2000005582A3 Optical disc-based assay devices and methods
06/29/2000WO2000004893A3 Imidazoline receptor binding compounds
06/29/2000WO2000004388A3 System for the quantification of platelet activation
06/29/2000WO2000003223A3 Method for measuring volatile organic compounds and a kit for sa me
06/29/2000WO2000001817A3 Mammalian genes; dendritic cell prostaglandin-like transponder (dc-pgt), hdtea84, hsljd37r and rankl, hcc5 chemokine, deubiquitinating 11 and 12 (dub11, dub12), md-1, md2 and cyclin e2, related reagents and methods
06/29/2000WO2000000610A3 Human signal peptide-containing proteins
06/29/2000WO1999067425A9 Binding acceleration techniques for the detection of analytes
06/29/2000WO1999066321A3 Pattern recognition proteins with lectin homology from several animal species and method to use them for measure or modulate innate resistance against bacteria and other pathogenic agents
06/29/2000WO1999064861A3 Method of identifying antidepressant compounds
06/29/2000WO1999064034A9 β2-ADRENERGIC RECEPTOR AGONISTS
06/29/2000DE3745131C2 Agglutinographic chamber for immunochemical liquid reagents
06/29/2000DE19909771A1 Substanz zur Gewinnung hochwirksamer Tumorarzneien sowie Verfahren Substance for the production of highly effective tumor drugs and methods
06/29/2000DE19859274A1 Vorrichtung zur Erkennung von Fremdstoffen in strangförmigen textilen Material A device for detecting foreign substances in a strand-like textile material
06/29/2000DE19858022A1 Mobile gas concentration measurement and mapping unit uses satellite locational system and telemetric data transmission
06/29/2000DE19856259A1 Verfahren zur Untersuchung eines erstarrenden und/oder erhärtenden Werkstoffs mittels Ultraschalls A method for examining a solidifying and / or hardening material using ultrasound
06/29/2000DE19854808A1 Detektionsverfahren Detection method
06/29/2000DE19854195A1 Verfahren zur Identifikation der Funktion von biologischen Molekülen und Vorrichtung zur Durchführung des Verfahrens A method for identifying the function of biological molecules and apparatus for carrying out the method
06/29/2000CA2358086A1 Protein-protein interactions in neurodegenerative disorders
06/29/2000CA2356987A1 Compounds for immunotherapy and diagnosis of colon cancer and methods for their use
06/29/2000CA2356887A1 Assays for ligands for nuclear receptors
06/29/2000CA2356852A1 Apparatus and method for concurrent chemical synthesis
06/29/2000CA2356765A1 Bone resorption inhibitors
06/29/2000CA2356764A1 Type iii secretion system antigens from bordetella pertussis
06/29/2000CA2356738A1 Monoclonal antibody against apolipoprotein a-1
06/29/2000CA2356344A1 Fluorescent dyes for solid phase and solution phase screening
06/29/2000CA2356215A1 Human monoclonal antibodies to ctla-4
06/29/2000CA2356174A1 Kidney disease detection and treatment
06/29/2000CA2356155A1 Cell lineage markers
06/29/2000CA2355896A1 Antibodies to truncated vegf-d and uses thereof
06/29/2000CA2355879A1 Pharmaceutical compositions comprising immortalised endothelial cells
06/29/2000CA2355876A1 Chlamydia trachomatis antigens
06/29/2000CA2355830A1 Crystalline form of activated trap and use thereof for structure-based drug design
06/29/2000CA2355631A1 Msh5 ablated mice and uses therefor
06/29/2000CA2355365A1 Nucleic acid sequencing method
06/29/2000CA2354843A1 Outer surface proteins, their genes, and their use
06/29/2000CA2354682A1 Method for the detection of specific nucleic acid sequences by polymerase nucleotide incorporation
06/29/2000CA2354369A1 Complementary dna's encoding proteins with signal peptides
06/29/2000CA2354135A1 Group b streptococcus proteins, and their use
06/29/2000CA2354074A1 Method of identifying a psychotropic agent using differential gene expression
06/29/2000CA2353876A1 A method and an apparatus for cutting of tissue blocks
06/29/2000CA2353775A1 Compositions and methods for the treatment of tumor
06/29/2000CA2353461A1 Integrated portable biological detection system
06/29/2000CA2352471A1 Compositions and methods for generating monoclonal antibodies representative of a specific cell type
06/29/2000CA2352203A1 Bioassay for identifying estrogen receptor-.beta./.alpha. selective modulators
06/29/2000CA2321187A1 Rna polymerase transcription promoters and method for determining base sequence
06/29/2000CA2320923A1 Laboratory test for assessing the tendency of a gasoline, optionally containing an additive, to cause deposits while the engine is running
06/29/2000CA2256128A1 Coded dna processing
1 ... 3100 3101 3102 3103 3104 3105 3106 3107 3108 3109 3110 3111 3112 3113 3114 3115 3116 3117 3118 3119 3120 ... 3937